MORGAN STANLEY - IMMIX BIOPHARMA INC ownership

IMMIX BIOPHARMA INC's ticker is and the CUSIP is 45258H106. A total of 17 filers reported holding IMMIX BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of IMMIX BIOPHARMA INC
ValueSharesWeighting
Q3 2023$1,368
+68300.0%
400
+39900.0%
0.00%
Q4 2022$21
-66.7%
0.00%
Q3 2022$030.00%
Other shareholders
IMMIX BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
XTX Topco Ltd 12,992$31,0000.01%
Virtu Financial LLC 23,515$57,0000.00%
InterOcean Capital Group, LLC 15,900$38,0000.00%
WELLS FARGO & COMPANY/MN 26$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
BlackRock Inc. 9,415$22,0000.00%
Citadel Advisors 21,713$52,0000.00%
Renaissance Technologies 62,600$151,0000.00%
OSAIC HOLDINGS, INC. 350$1,0000.00%
View complete list of IMMIX BIOPHARMA INC shareholders